DRG uses cookies to improve your experience on this website. Some of the cookies we use are essential for parts of the website to operate. Please be aware that if you continue without changing your cookie settings, you consent to this. For more information on our use of cookies, please review our cookie policy.

New look. Same commitment. Decision Resources Group becomes Clarivate. Read more here

2 search results for: biopharma-insights

If you didn't find what you were looking for, try again!

Home › Search for "biopharma insights"

Possible Implications of FDA’s Decision on Plazomicin

On June 26, Achaogen’s Zemdri (plazomicin) obtained a bittersweet victory: the FDA approved its use in complicated urinary tract infections (cUTI...

In DRG Blog/ June, 2018

ECCMID 2018: Conference Highlights

DRG highlights some of the most interesting findings at the 28th ECCMID Recently I had the opportunity to attend the 28th European Conference on...

In DRG Blog/ June, 2018

1-2 of 2